Search results for “cancerimmunotherapy”

#cancerimmunotherapy #hematologicmalignancies

#NorthAmerica

Corey is founder and chief technology officer of CERo Therapeutics. A board-certified hematologist, Dr. Corey led the foundational discovery research to identify and define the therapeutic utility of

#cancerimmunotherapy #drugdiscovery

#NorthAmerica

Kutlu is currently working as a Senior Director, Research Lead - Immunology at Sana Biotechnology, Inc.

#CancerImmunotherapy #Immunology

#Europe

Livija Deban is currently Chief Scientific Officer at Prokarium

#immunology #cancerimmunotherapy

#NorthAmerica

At Century Therapeutics, Luis is responsible for overseeing the research and development of genetically engineered iPSCs-derived immune cell products to treat hematologic and solid tumors.

#tcell #cancer #vaccines #epivaxtherapeutics #cancerimmunotherapy

#NorthAmerica

Nicole Ruggiero Chief Executive Officer, EpiVax Therapeutics

#highthroughputscreening #cancerimmunotherapy

#NorthAmerica

Tumor immunologist with a particular focus on innate immunity (macrophages), breast cancer, advanced spatial biology, and tech development. Strong background in high-throughput discovery screens in im

#immunology #cancerimmunotherapy

#NorthAmerica

American Cancer Society professor. Multiple fundamental discoveries in Immunology, Anti-tumor Immunity, and Cancer Immunotherapy, with over 220 peer-reviewed publications. Defined the T cell-inflamed/

#microfluidics #cancerimmunotherapy

#NorthAmerica

Dr. Weiqiang Chen is an Associate Professor of Biomedical Engineering and Mechanical Engineering and leads the Applied Micro-Bioengineering Laboratory at New York University. His research lab develops